Delivery Order SPE2DB20D2014-SPE2DB24FC65E

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The contract has a ceiling value of $2,375.20 and a completion date of August 7, 2024. This award is a firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The firm-fixed-price delivery order has a ceiling value of $1,176.22 and an ultimate completion date of March 11, 2025. The contract is not designated under a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The award has a ceiling value of $2,779.32 and an ultimate completion date of August 6, 2024. The contract is a firm-fixed-price delivery order, which means the price is predetermined and not subject to adjustment. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,697.74 and is a delivery order for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract is a firm fixed-price agreement with an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar, a 100 unit/mL, 3 mL insulin product, with a ceiling value of $2,415.58 and a period of performance through January 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The contract has a firm fixed price of $1,227.36 and an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The award has a ceiling value of $1,125.08 and an ultimate completion date of November 26, 2024. This contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. federal government. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product, with a ceiling value of $6,630.08 and a period of performance through May 28, 2024. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, and has a ceiling value of $6,880.85. The contract is a firm fixed-price award with a completion date of May 22, 2024. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty insulin medication, at a total ceiling value of $3,671.01. The contract is a Firm Fixed Price arrangement with an ultimate completion date of August 5, 2024. This order is not set aside for any specific business type....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC65E
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML insulin products. The contract has a ceiling value of $3,523.08 and an ultimate completion date of August 5, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific Delivery Order is part of that broader IDC, enabling the DLA to efficiently procure essential pharmaceutical products from AmerisourceBergen to support the healthcare needs of military personnel and other federal beneficiaries.

Generated 11/1/24, 9:20 AM